EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)VergleichsstudieRandomisierte kontrollierte Studie

Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia

Leslie Citrome, Sergey Yagoda, Ilda Bidollari, Meihua Wang

The Journal of Clinical Psychiatry · 2024

DOI: 10.4088/jcp.23m15095 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift The Journal of Clinical Psychiatry, 2024. Verfasst von Leslie Citrome und 3 weiteren Autor:innen. Beteiligte Einrichtung: New York Medical College, Valhalla, New York. Hauptthemen laut MEDLINE: Antipsychotic Agents, Hypotension, Nanoparticles, Noncommunicable Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsHypotensionNanoparticlesNoncommunicable DiseasesSchizophreniaAdultFemaleHumansMaleAripiprazoleDelayed-Action PreparationsPaliperidone PalmitateProlactinTreatment OutcomeWeight GainDouble-Blind Method

Substanzen

Antipsychotic AgentsAripiprazolearipiprazole lauroxilDelayed-Action PreparationsPaliperidone PalmitateProlactin

Autor:innen und Institutionen

  • New York Medical College, Valhalla, New York.
  • Corresponding Author: Leslie Citrome, MD, MPH, New York Medical College, 40 Sunshine Cottage Rd, Valhalla, NY 10595 (nntman@gmail.com).
  • Alkermes, Inc., Waltham, Massachusetts.

Zitieren

APA

Citrome, L., Yagoda, S., Bidollari, I., & Wang, M. (2024). Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.23m15095

Vancouver

Citrome L, Yagoda S, Bidollari I, Wang M. Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia. The Journal of Clinical Psychiatry. 2024. doi:10.4088/jcp.23m15095

BibTeX
@article{Citrome2024,
  author = {Citrome, Leslie and Yagoda, Sergey and Bidollari, Ilda and Wang, Meihua},
  title = {Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia},
  journal = {The Journal of Clinical Psychiatry},
  year = {2024},
  doi = {10.4088/jcp.23m15095}
}
Kostenlos starten →